<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastasis</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is a leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Myeloid cells play pivotal roles in the metastatic process, but their prometastatic functions in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> remain incompletely understood </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate their role, we simulated <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in C57BL/6 mice through intrasplenic inoculation of MC38 colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells </plain></SENT>
<SENT sid="3" pm="."><plain>Among the <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> myeloid infiltrate, we identified a distinct population of CD11b/Gr1(mid) cells different from other myeloid populations previously associated with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>These cells increased in number dramatically during establishment of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> and were recruited from bone marrow by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-derived CCL2 </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastasis</z:e> of Lewis <z:mp ids='MP_0008714'>lung carcinoma</z:mp> cells followed this pattern but this mechanism is not universal as liver colonization by B16F1 <z:hpo ids='HP_0002861'>melanoma</z:hpo> cells did not recruit similar subsets </plain></SENT>
<SENT sid="6" pm="."><plain>Inhibition of CCL2 signaling and absence of its cognate receptor CCR2 reduced CD11b/Gr1(mid) recruitment and decreased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> burden </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_63'>Depletion</z:mpath> of the CD11b/Gr1(mid) subset in a transgenic CD11b-<z:e sem="disease" ids="C0012546" disease_type="Disease or Syndrome" abbrv="">diphtheria</z:e> toxin receptor mouse model markedly reduced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation </plain></SENT>
<SENT sid="8" pm="."><plain>There was no evidence for involvement of an adaptive immune response in the prometastatic effects of CD11b/Gr1(mid) cells </plain></SENT>
<SENT sid="9" pm="."><plain>Additionally, an analogous myeloid subset was found in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> of some <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Collectively, our findings highlight the importance of myeloid cells--in this case a selective CD11b/Gr1(mid) subset--in sustaining development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and identify a potential target for antimetastatic therapy </plain></SENT>
</text></document>